R. Dean

发表

of IL-6from LPS-induced signs of sickness independent Bcl-2 mediates sex-specific differences in recovery of

K. Korach, C. Overall, Y. Tesfaigzi, 2015 .

NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats

Angela Hussainkhel, S. Decker, Matthew Waldbrook, 2021, bioRxiv.

Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.

C. Overall, A. Doucet, Amanda E Starr, 2008, Blood.

Macrophage-speciﬁc metalloelastase (MMP-12) truncates and inactivates ELR (cid:1) CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte inﬂux

C. Overall, A. Doucet, Amanda E Starr, 2008 .

Identiﬁcation of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Afﬁn Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Comp

C. Overall, G. Butler, J. Courty, 2007 .

Inhibitory effects of cannabidiol on voltage-dependent sodium currents

P. Ruben, S. Goodchild, R. Dean, 2018, The Journal of Biological Chemistry.

Comparison of Adipose Stromal Vascular Fraction and Placental Cell Extract to Expanded Adipose, Placental, and Umbilical Cord Mesenchymal Stem Cells

J. Musick, R. Dean, Tiana Tonrey, 2018 .

Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S

Christopher M Overall, C. Overall, Richard A Dean, 2007, Molecular & Cellular Proteomics.

Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer

Christopher M. Overall, C. Overall, Richard A. Dean, 2006, Cancer and Metastasis Reviews.

Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co

C. Overall, G. Butler, J. Courty, 2007, Molecular and Cellular Biology.

Identification of a Putative Tdp1 Inhibitor (CD00509) by in Vitro and Cell-Based Assays

Steven J. M. Jones, C. Boerkoel, Jianghong An, 2014, Journal of biomolecular screening.

Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding

C. Overall, E. Tam, G. Butler, 2008, Molecular and Cellular Biology.

Proteomic Identification of Cellular Protease Substrates Using Isobaric Tags for Relative and Absolute Quantification (iTRAQ)

C. Overall, Derek Smith, R. Dean, 2007, Current protocols in protein science.

LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity

X. Puente, C. López-Otín, C. Overall, 2007, PloS one.

Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion.

T. Morris, S. Watson, J. Scholefield, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates.

C. Overall, Derek Smith, G. Butler, 2009, Methods in molecular biology.

Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding*

Christopher M. Overall, C. Overall, J. Cox, 2008, Journal of Biological Chemistry.

Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.

Andrea Lindgren, L. Lin, Shaoyi Sun, 2013, Bioorganic & medicinal chemistry.

Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310.

D. Sutherlin, Jun Chen, D. Hackos, 2021, Journal of medicinal chemistry.

Molecular pharmacology of selective Nav1.6 and dual Nav1.6 and Nav1.2 channel inhibitors that suppress excitatory neuronal activity ex vivo

P. Ruben, Matthew Waldbrook, R. R. Parrish, 2023, bioRxiv.